Pfizer Relocates Global Headquarters
The New York City-based company will relocate to another building in the city.
Pfizer announced on April 10, 2018 that it has signed a 20-year lease for The Spiral, an office tower being built by Tishman Speyer, and will relocate its global headquarters from East 42nd Street, which the company has occupied since 1961.
The company will occupy 15 floors at The Spiral and expects to begin moving colleagues there in 2022. The East 42nd Street property is currently in the process of being sold by Pfizer.
“Pfizer’s history in New York City began in 1849, and we are proud to continue our commitment to the city with our move to The Spiral in Manhattan,” said Albert Bourla, chief operating officer at Pfizer, in a company press release. “In relocating our headquarters, we sought to provide our colleagues a modern, state-of-the-art headquarters that would foster greater collaboration and innovation in a vibrant neighborhood in Manhattan.”
Source: Pfizer
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
